Jennifer Greufe has used her expertise to combat some of the most common health conditions facing patients around the world. Among other projects, she has spearheaded pharma sponsorships of programs for the American Heart Association and the American Diabetes Association. Over the years, Greufe has also assisted on a cardio health awareness campaign featuring Maya Angelou on behalf of Novartis and served on the launch team for Bristol-Myers Squibb’s HIV treatment Atripla.
Greufe helped strengthen the bonds between BMS and the local HIV patient communities via Light to Unite, an initiative that raised donations to benefit grassroots HIV/AIDS organizations throughout the country. Her teams also helped launch Amgen’s Repatha, a breakthrough cholesterol treatment, and Eli Lilly/Boehringer Ingelheim’s Jardiance, a first-in-class diabetes treatment.